Description
Cardiac Markers
Cardiac Markers provides market and competitive analysis for tests for cardiovascular disease (CVD) that use biomarkers, including the global CVD biomarkers diagnostic market in 2015 and 2020. The report discusses selected biomarkers and biomarker panels for CVD and the manufacturers developing and marketing these. The report also notes selected lipid biomarkers and the manufacturers developing and marketing these. Cardiac Markers notes trends in test strategies as well. Beckman Coulter, Inc. (subsidiary of Danaher Corporation), bioMérieux SA, Quest Diagnostics, Roche, and Siemens are among those discussed in the competitor analysis.
Table of Contents
ONE: EXECUTIVE SUMMARY
TWO: INTRODUCTION
Overview
Cardiac Risk
Genetics and Cardiovascular Disease
Acute Myocardial Infarction and Acute Coronary Syndrome
Heart Failure
Lipid Disorders
ACP Coronary Heart Disease Screening
THREE: MARKET ANALYSIS
FOUR: COMPANY PROFILES
Abbott Laboratories
Recent Revenue History
Company Overview – Focusing on Biomarkers
ALPCO
ARUP Laboratories
Recent Revenue History
Company Overview
Axis-Shield Diagnostics, Ltd. (An Alere Company)
Recent Revenue History
Company Overview
Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
Recent Revenue History
Company Overview
bioMérieux SA
Recent Revenue History
Company Overview
CardioDx, Inc.
CardioGenics Holdings Inc.
Gamma Therapeutics, Inc.
Ortho-Clinical Diagnostics
Recent Revenue History
Company Overview
Quest Diagnostics
Recent Revenue History
Cardiovascular Testing
Oncology
Toxicology
Randox Laboratories Ltd.
Recent Revenue History
Company Overview
RENESE UG
Roche
Recent Revenue History
Company Overview
Recent Revenue History
Company Overview
Tosoh Corporation
Tosoh Bioscience, Inc.
Recent Revenue History
Company Overview
LIST OF EXHIBITS
TWO: INTRODUCTION
Table 2-1: Selected IVD Markers of Cardiovascular Disease (CVD)
Table 2-2: Selected Biomarkers and Biomarker Panels for Cardiovascular Disease, and Companies Developing/Marketing These Biomarkers
Table 2-3: Selected Lipid Biomarkers, and Companies Developing/Marketing These Biomarkers
THREE: MARKET ANALYSIS
Table 3-1: Worldwide Cardiovascular Disease Biomarkers Diagnostic Market –2015 and 2020
